Is Teva Pharmaceutical Industries Limited overvalued?

Teva Pharmaceutical Industries Limited (TEVA) looks undervalued — trading about 118% below its fair value.

Undervalued

Price

$34.64

Fair value

$75.43

Current P/E

11.8

Normal P/E

25.7

Market cap

$40.34B

Dividend yield

0.0%

Return on equity

19.3%

Sector

Healthcare

Fair value compares TEVA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 4 Jul 2026.

Related stocks